84 related articles for article (PubMed ID: 27352793)
1. Inflammatory responses increase secretion of MD-1 protein.
Thomas Jennings R; Odkhuu E; Nakashima A; Morita N; Kobayashi T; Yamai I; Tanaka M; Suganami T; Haga S; Ozaki M; Watanabe Y; Nagai Y; Takatsu K; Kikuchi-Ueda T; Ichimonji I; Ogawa Y; Takagi H; Yamazaki T; Miyake K; Akashi-Takamura S
Int Immunol; 2016 Oct; 28(10):503-512. PubMed ID: 27352793
[TBL] [Abstract][Full Text] [Related]
2. The RP105/MD-1 complex is indispensable for TLR4/MD-2-dependent proliferation and IgM-secreting plasma cell differentiation of marginal zone B cells.
Nagai Y; Yanagibashi T; Watanabe Y; Ikutani M; Kariyone A; Ohta S; Hirai Y; Kimoto M; Miyake K; Takatsu K
Int Immunol; 2012 Jun; 24(6):389-400. PubMed ID: 22354914
[TBL] [Abstract][Full Text] [Related]
3. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide.
Nagai Y; Shimazu R; Ogata H; Akashi S; Sudo K; Yamasaki H; Hayashi S; Iwakura Y; Kimoto M; Miyake K
Blood; 2002 Mar; 99(5):1699-705. PubMed ID: 11861286
[TBL] [Abstract][Full Text] [Related]
4. The radioprotective 105/MD-1 complex links TLR2 and TLR4/MD-2 in antibody response to microbial membranes.
Nagai Y; Kobayashi T; Motoi Y; Ishiguro K; Akashi S; Saitoh S; Kusumoto Y; Kaisho T; Akira S; Matsumoto M; Takatsu K; Miyake K
J Immunol; 2005 Jun; 174(11):7043-9. PubMed ID: 15905547
[TBL] [Abstract][Full Text] [Related]
5. Serum soluble MD-1 levels increase with disease progression in autoimmune prone MRL(lpr/lpr) mice.
Sasaki S; Nagai Y; Yanagibashi T; Watanabe Y; Ikutani M; Kariyone A; Tsuneyama K; Hirai Y; Takatsu K
Mol Immunol; 2012 Jan; 49(4):611-20. PubMed ID: 22118968
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of mouse and human RP105/MD-1 complexes reveal unique dimer organization of the toll-like receptor family.
Ohto U; Miyake K; Shimizu T
J Mol Biol; 2011 Nov; 413(4):815-25. PubMed ID: 21959264
[TBL] [Abstract][Full Text] [Related]
7. A Novel Gene Delivery Vector of Agonistic Anti-Radioprotective 105 Expressed on Cell Membranes Shows Adjuvant Effect for DNA Immunization Against Influenza.
Yamazaki T; Biswas M; Kosugi K; Nagashima M; Inui M; Tomono S; Takagi H; Ichimonji I; Nagaoka F; Ainai A; Hasegawa H; Chiba J; Akashi-Takamura S
Front Immunol; 2020; 11():606518. PubMed ID: 33414788
[TBL] [Abstract][Full Text] [Related]
8. The radioprotective 105/MD-1 complex contributes to diet-induced obesity and adipose tissue inflammation.
Watanabe Y; Nakamura T; Ishikawa S; Fujisaka S; Usui I; Tsuneyama K; Ichihara Y; Wada T; Hirata Y; Suganami T; Izaki H; Akira S; Miyake K; Kanayama HO; Shimabukuro M; Sata M; Sasaoka T; Ogawa Y; Tobe K; Takatsu K; Nagai Y
Diabetes; 2012 May; 61(5):1199-209. PubMed ID: 22396206
[TBL] [Abstract][Full Text] [Related]
9. Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1.
Miyake K; Ogata H; Nagai Y; Akashi S; Kimoto M
J Endotoxin Res; 2000; 6(5):389-91. PubMed ID: 11521060
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of TLR-4/MD-2 signaling by RP105/MD-1.
Divanovic S; Trompette A; Atabani SF; Madan R; Golenbock DT; Visintin A; Finberg RW; Tarakhovsky A; Vogel SN; Belkaid Y; Kurt-Jones EA; Karp CL
J Endotoxin Res; 2005; 11(6):363-8. PubMed ID: 16303092
[TBL] [Abstract][Full Text] [Related]
11. Involvement of RP105 and toll-like receptors in the activation of mouse peritoneal macrophages by Staphylococcus aureus.
Liu B; Fu Y; Feng S; Zhang X; Liu Z; Cao Y; Li D; Liang D; Li F; Zhang N; Yang Z
Scand J Immunol; 2013 Jul; 78(1):8-16. PubMed ID: 23521167
[TBL] [Abstract][Full Text] [Related]
12. Role of TLR4/MD-2 and RP105/MD-1 in innate recognition of lipopolysaccharide.
Kimoto M; Nagasawa K; Miyake K
Scand J Infect Dis; 2003; 35(9):568-72. PubMed ID: 14620136
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105.
Divanovic S; Trompette A; Atabani SF; Madan R; Golenbock DT; Visintin A; Finberg RW; Tarakhovsky A; Vogel SN; Belkaid Y; Kurt-Jones EA; Karp CL
Nat Immunol; 2005 Jun; 6(6):571-8. PubMed ID: 15852007
[TBL] [Abstract][Full Text] [Related]
14. Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice.
Kobayashi T; Takahashi K; Nagai Y; Shibata T; Otani M; Izui S; Akira S; Gotoh Y; Kiyono H; Miyake K
Int Immunol; 2008 Jul; 20(7):881-91. PubMed ID: 18492657
[TBL] [Abstract][Full Text] [Related]
15. RP105 is associated with MD-1 and transmits an activation signal in human B cells.
Miura Y; Shimazu R; Miyake K; Akashi S; Ogata H; Yamashita Y; Narisawa Y; Kimoto M
Blood; 1998 Oct; 92(8):2815-22. PubMed ID: 9763566
[TBL] [Abstract][Full Text] [Related]
16. An unusual dimeric structure and assembly for TLR4 regulator RP105-MD-1.
Yoon SI; Hong M; Wilson IA
Nat Struct Mol Biol; 2011 Aug; 18(9):1028-35. PubMed ID: 21857663
[TBL] [Abstract][Full Text] [Related]
17. [Functional roles of TLR4/MD-2 and RP105/MD-1 in innate recognition of LPS].
Kusumoto Y; Miyake K
Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2103-8. PubMed ID: 12518421
[No Abstract] [Full Text] [Related]
18. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
[TBL] [Abstract][Full Text] [Related]
19. TLR accessory molecule RP105 (CD180) is involved in post-interventional vascular remodeling and soluble RP105 modulates neointima formation.
Karper JC; Ewing MM; de Vries MR; de Jager SC; Peters EA; de Boer HC; van Zonneveld AJ; Kuiper J; Huizinga EG; Brondijk TH; Jukema JW; Quax PH
PLoS One; 2013; 8(7):e67923. PubMed ID: 23844130
[TBL] [Abstract][Full Text] [Related]
20. Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expression.
Miyake K; Shimazu R; Kondo J; Niki T; Akashi S; Ogata H; Yamashita Y; Miura Y; Kimoto M
J Immunol; 1998 Aug; 161(3):1348-53. PubMed ID: 9686597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
